Skip to main content
. 2022 Nov 21;194(45):E1529–E1536. doi: 10.1503/cmaj.220676

Table 1:

Descriptive statistics among patients with myocarditis within 7 or 21 days after SARS-CoV-2 vaccination

Variable No. of patients with myocarditis within 7 days* No. of patients with myocarditis within 21 days*


Male
n = 80
Female
n = 19
Male
n = 105
Female
n = 36
Age, yr

 Range 12–82 15–80 12–87 15–88

 Mean ± SD 28 ± 16 45 ± 21 31 ± 17 49 ± 22

 Median (IQR) 22 (18–31) 46 (25–62) 24 (19–38) 53 (31–68)

Vaccine type

 Pfizer

  Dose 1 5 0 15 5

  Dose 2 29 8 34 14

  Dose 3 8 2 12 4

 Moderna

  Dose 1 2 0 5 1

  Dose 2 32 5 33 7

  Dose 3 4 4 6 5

Note: IQR = interquartile range, Moderna = mRNA-1273 (Moderna), Pfizer = BNT162b2 (Pfizer-BioNTech), SD = standard deviation.

*

Unless indicated otherwise.